Objective: Treatment of acute lymphoblastic leukemia (ALL) in adults focuses on the initial assessment of the prognostic relevant cytogenetic features as well as a response-guided therapy based on molecular data. We examined the importance of molecular-cytogenetic abnormalities for complete remission (CR) rates and the overall survival (OS) in adult ALLs
Cytogenetic classification of 350 adults with acute lymphoblastic leukaemia on MRC UKALL XA trial sh...
Multiple cytogenetic subgroups have been described in adult Philadelphia chromosome (Ph)-negative B-...
The biology and outcome of adult T-cell acute lymphoblastic leukemia are poorly understood. We prese...
Objective: Treatment of acute lymphoblastic leukemia (ALL) in adults focuses on the initial assessme...
Pretreatment cytogenetics is a known predictor of outcome in hematologic malignancies. However, its ...
Pre-treatment cytogenetics is a known predictor of outcome in haematological malignancies. However, ...
The potential prognostic value of conventional karyotyping in adult T-cell acute lymphoblastic leuke...
This review focuses on the most recent advances in the diagnostic and prognostic work-up of adult ac...
BCR-ABL, t(4;11)/MLL-AF4, t(1;19)/E2APBX1, 901p15-p16 deletions, 6q deletions, miscellaneous structu...
During the last decade a tremendous technologic progress based on genome-wide profiling of genetic a...
OBJECTIVES: To study the pattern of chromosomal abnormalities in adult patients with acute lymphobla...
Multiple cytogenetic subgroups have been described in adult Philadelphia chromosome (Ph)-negative B-...
With intensified pediatric-like therapy and genetic disease dissection, the field of adult acute lym...
Acute lymphoblastic leukemia (ALL) in adults is a rare malignancy. It represents 1-2% of all cancers...
Multiple cytogenetic subgroups have been described in adult Philadelphia chromosome (Ph)-negative B-...
Cytogenetic classification of 350 adults with acute lymphoblastic leukaemia on MRC UKALL XA trial sh...
Multiple cytogenetic subgroups have been described in adult Philadelphia chromosome (Ph)-negative B-...
The biology and outcome of adult T-cell acute lymphoblastic leukemia are poorly understood. We prese...
Objective: Treatment of acute lymphoblastic leukemia (ALL) in adults focuses on the initial assessme...
Pretreatment cytogenetics is a known predictor of outcome in hematologic malignancies. However, its ...
Pre-treatment cytogenetics is a known predictor of outcome in haematological malignancies. However, ...
The potential prognostic value of conventional karyotyping in adult T-cell acute lymphoblastic leuke...
This review focuses on the most recent advances in the diagnostic and prognostic work-up of adult ac...
BCR-ABL, t(4;11)/MLL-AF4, t(1;19)/E2APBX1, 901p15-p16 deletions, 6q deletions, miscellaneous structu...
During the last decade a tremendous technologic progress based on genome-wide profiling of genetic a...
OBJECTIVES: To study the pattern of chromosomal abnormalities in adult patients with acute lymphobla...
Multiple cytogenetic subgroups have been described in adult Philadelphia chromosome (Ph)-negative B-...
With intensified pediatric-like therapy and genetic disease dissection, the field of adult acute lym...
Acute lymphoblastic leukemia (ALL) in adults is a rare malignancy. It represents 1-2% of all cancers...
Multiple cytogenetic subgroups have been described in adult Philadelphia chromosome (Ph)-negative B-...
Cytogenetic classification of 350 adults with acute lymphoblastic leukaemia on MRC UKALL XA trial sh...
Multiple cytogenetic subgroups have been described in adult Philadelphia chromosome (Ph)-negative B-...
The biology and outcome of adult T-cell acute lymphoblastic leukemia are poorly understood. We prese...